Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
International Journal of Clinical Pharmacy
Metadata
Title
Comparative safety of antipsychotics in the WHO pharmacovigilance database: the haloperidol case
Publication date
01-10-2011
Published in
International Journal of Clinical Pharmacy / Issue 5/2011
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-011-9541-y

Other articles of this Issue 5/2011

International Journal of Clinical Pharmacy 5/2011 Go to the issue

Research Article

Factors related to high and low levels of drug adherence according to patients with type 2 diabetes

Letter to the Editor

Role of the hospital pharmacy and therapeutics committee in detecting and regulating off-label drug use

Short Research Report

The clinical pharmacist’s contributions within the multidisciplinary patient care team of an intern nephrology ward

Research Article

Interactions between parents/carers of pre-school children and pharmacy staff when buying non-prescription medicines

Research Article

Determinants of self medication practices among pregnant women in Ibadan, Nigeria

Research Article

Medication counselling and dispensing practices at community pharmacies: a comparative cross sectional study from Pakistan

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits